News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
312 Results
Type
Article (5)
Company Profile (1)
Press Release (306)
Section
Business (58)
Deals (11)
Drug Development (105)
FDA (5)
Job Trends (3)
News (188)
Policy (26)
Tag
Alliances (15)
Antibody-drug conjugate (ADC) (1)
Approvals (5)
Best Places to Work (1)
Biotechnology (1)
Cell therapy (2)
Clinical research (90)
Collaboration (1)
CRISPR (1)
Earnings (24)
Editorial (1)
Events (31)
Executive appointments (1)
FDA (6)
Funding (1)
Gene editing (1)
Gene therapy (2)
IPO (5)
Job creations (2)
Legal (1)
Manufacturing (1)
Mergers & acquisitions (5)
Metabolic disorders (1)
NextGen: Class of 2026 (3)
Obesity (1)
People (18)
Phase 1 (7)
Phase 2 (49)
Phase 3 (37)
Pipeline (1)
Postmarket research (3)
Preclinical (9)
Radiopharmaceuticals (1)
Rare diseases (1)
Regulatory (27)
Series B (1)
Startups (2)
Vaccines (3)
Venture capital (1)
Date
Last 365 days (6)
2026 (1)
2025 (8)
2024 (9)
2023 (6)
2022 (3)
2021 (3)
2020 (9)
2019 (7)
2018 (7)
2017 (22)
2016 (18)
2015 (24)
2014 (24)
2013 (38)
2012 (35)
2011 (31)
2010 (27)
Location
Asia (11)
Australia (3)
California (2)
China (1)
Europe (23)
Massachusetts (2)
Nevada (1)
Pennsylvania (1)
South America (1)
Southern California (2)
United States (5)
312 Results for "exsilio therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Exsilio Launches With $82M to Tackle Gene Therapy Challenges in Novel Approach
Exsilio Therapeutics emerged from stealth on Tuesday with a platform that leverages mRNA technology to develop redosable genomic medicines for a range of complex diseases.
June 25, 2024
·
4 min read
·
Ben Hargreaves
Genetown
Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases
Exsilio Therapeutics, a biotechnology company developing genomic medicines for a broad range of diseases, announced its emergence from stealth with $82 million in Series A financing.
June 25, 2024
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
January 7, 2026
·
5 min read
Averna Therapeutics
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Press Releases
aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
June 4, 2025
·
7 min read
Venture capitalists
The Megaround Ruled Biopharma in 2024 as First-Time VC Funding Doubled
Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 deals in 2023.
January 9, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
June 11, 2025
·
11 min read
Press Releases
iPSC-CAR-NK Cell Therapy Clinical Result Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatment
June 26, 2025
·
4 min read
1 of 32
Next
